Evidence map›Paper›PMID 28937848›Full record

ArticleSLAS discovery : advancing life sciences R & D2018

MightyScreen: An Open-Source Visualization Application for Screening Data Analysis.

Longfei Wang, Qin Yang, Adriana Jaimes, Tianyu Wang, Hendrik Strobelt, Jenny Chen, Piotr Sliz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in SLAS discovery : advancing life sciences R & D, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Longfei Wang1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Qin Yang1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Adriana Jaimes1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Tianyu Wang2 Department of Physiology and Biophysics, University of California, Irvine, CA, USA.
Hendrik Strobelt3 School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Jenny Chen4 Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Piotr Sliz1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.

Funding

Structural and Mechanistic Studies of Regulation of let-7 biogenesis by Lin28'R01CA163647 · NCI · HARVARD MEDICAL SCHOOL · PI SLIZ, PIOTR · 2012 to 2016
$1.7M
NCI NIH HHS R01 CA163647
6 · The paper itself

Abstract

Screening is a methodology widely used in biological and biomedical research. There are numerous visualization methods to validate screening data quality but very few visualization applications capable of hit selection. Here, we present MightyScreen ( mightyscreen.net ), a novel web-based application designed for visual data evaluation as well as visual hit selection. We believe MightyScreen is an intuitive and interactive addition to conventional hit selection methods. We also provide study cases showing how MightyScreen is used to visually explore screening data and make hit selections.

Indexed as

ComputersData AnalysisHigh-Throughput Screening AssaysInternetSoftwareUser-Computer Interfacehit selectioninteractive visualizationopen sourcescreeningvisualization

Identifiers

PMID28937848
PMCPMC13336235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.